| Metric | FY 2025↕ |
|---|---|
| Revenue | $0.6B |
| Cost of Revenue | — |
| Gross Profit | — |
| R&D Expense | — |
| SG&A Expense | $0.0B |
| Operating Income | $0.5B |
| Net Income | $0.4B |
| EPS (Basic) | $2.44 |
| EPS (Diluted) | $2.44 |
| Metric | FY 2025↕ |
|---|---|
| Total Assets | $9.3B |
| Current Assets | — |
| Cash & Equivalents | $0.0B |
| Total Liabilities | $3.4B |
| Current Liabilities | — |
| Stockholders' Equity | $5.9B |
| Metric | FY 2025↕ |
|---|---|
| Operating Cash Flow | $3.7B |
| Investing Cash Flow | $-5.7B |
| Capital Expenditures | — |
| Financing Cash Flow | $2.1B |